A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The study is designed to understand the blood concetration of PF-06412562 and its metabolite, PF-06663872, following a single oral dose of a modified release formulation. The study will include two doses of the PF-06412562 modified release formulation to understand the proportionality. Effect of food on absorption of PF-06412562 from the modified release formulation will also be investigated in this study.
Epistemonikos ID: a2d25fd26c8febe3b8db4109fc544bc96a7cb1a5
First added on: May 12, 2024